{"database": "lobbying", "table": "lobbying_activities", "rows": [[1344944, "54060356-5733-4454-ad16-c17845fd61d2", "Q4", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ASTRAZENECA", 2012, "fourth_quarter", "PHA", "**see addendum page Prescription drug importation\n     S. 319  Pharmaceutical Market Access and Drug Safety Act of 2011\n     H.R. 147 - Prescription Drug Affordability Act\n     H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act\n\nPL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation \n\n***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2013-01-18T15:10:12.193000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1344944"], "units": {}, "query_ms": 1.8630479462444782, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}